SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001383556-07-000001
Filing Date
2007-03-29
Accepted
2007-03-29 17:00:07
Documents
1
Period of Report
2006-07-05

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 2038
  Complete submission text file 0001383556-07-000001.txt   4103
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 21000
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 21000 972-4-988-9488
Protalix BioTherapeutics, Inc. (Issuer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: FL | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1428 BRICKELL AVENUE SUITE 105 MIAMI FL 33131
Business Address 305-371-4112
Lockshin Curtis (Reporting) CIK: 0001383556 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33357 | Film No.: 07728329